A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina

Published:2003-10 Issue:8 Volume:42 Page:1339-1347
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Grines Cindy L,Watkins Matthew W,Mahmarian John J,Iskandrian Ami E,Rade Jeffrey J,Marrott Pran,Pratt Craig,Kleiman Neal

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2;Simons;Circulation,2002

2. A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans;Eppler;Clin Pharmacol Ther,2002

3. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris;Grines;Circulation,2002

4. Quantitative adenosine 201 Tl-single-photon emission computer tomography for the early assessment of patients surviving acute myocardial infarction;Mahmarian;Circulation,1993

5. Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single photon emission computed tomography;Aoki;Am Heart J,1991

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy for atrial fibrillation;Journal of Molecular and Cellular Cardiology;2024-11

2. Gene therapy for polygenic or complex diseases;Biomarker Research;2024-09-04

3. RNF149 Destabilizes IFNGR1 in Macrophages to Favor Postinfarction Cardiac Repair;Circulation Research;2024-08-02

4. Fibroblast Growth Factors in Cardiovascular Disease;Journal of Atherosclerosis and Thrombosis;2024

5. Biomarkers to monitor the prognosis, disease severity, and treatment efficacy in coronary artery disease;Expert Review of Cardiovascular Therapy;2023-10-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3